| Friday, October 29, 2010 | |||||||||||
| Time | |||||||||||
| 08:30- 09:00am |
Welcome coffee and registration | P o s t e r E x h i b i t i o n |
I n d u s t r i a l E x h i b i t i o n |
||||||||
| 09:00- 09:50am |
Research in Germany – Land of ideas. Award ceremony for an idea dealing with magnetic infection diagnostics (in German language) |
||||||||||
09:50- |
Coffee break and guided tour through the exhibition "The experience of magnet technologies" (in German language) |
||||||||||
| 10:30am- 11:00pm |
Schultze, Joachim The need for novel biomarkers: A pre-requisite for novel immunotherapeutic strategies |
||||||||||
| Cell and immune therapy for neuronal and inflammatory disease | |||||||||||
| 11:00- 11:30am | Parolini, Ornella Placenta derived cells: Toward their application in inflammatory diseases |
||||||||||
| 11:30am- 12:00pm | Presentations from the abstracts | ||||||||||
| Cell and immune therapy: methods, manufacturing and regulation | |||||||||||
| 12:00- 12:30pm | Lehmann, Jörg | Schulz, Ronny Preclinical safety requirements for the approval of cell-based medicinal products – Demonstration of the safety testing concept at Fraunhofer IZI and TRM Leipzig |
||||||||||
| 12:30- 01:30pm |
Lunch break and poster viewing | ||||||||||
| 01:30- 02:00pm | Presentations from the abstracts | ||||||||||
| Cell and immune therapy for immune and autoimmune disorders | |||||||||||
| 02:00- 02:30pm | Stauss, Hans Josef Therapy of autoimmunity with gene modified T-cells |
||||||||||
| 02:30- 03:00pm | Halban, Philippe Challenges in moving beta cell replacement therapy from bench to bedside |
||||||||||
| 03:00- 03:30pm | Presentations from the abstracts | ||||||||||
| 03:30- 04:00pm |
Coffee break and poster viewing | ||||||||||
| Cell and immune therapy for oncological disease | |||||||||||
| 04:00- 04:30pm | Frazer, Neil CVac ® - a novel autologous dendritic cell therapy for ovarian carcinoma |
||||||||||
| 04:30- 05:00pm | Presentations from the abstracts | ||||||||||
| 05:00- 05:30pm | Grigoleit, Götz Ulrich Antigen specific cellular immunotherapy after allogeneic stem cell transplantation |
||||||||||
| 05:30- 06:00pm | Presentations from the abstracts | ||||||||||
| 7:00pm | Evening function at Bayerischer Bahnhof | ||||||||||
| Saturday, October 30, 2010 | |||||||||||
| Time | |||||||||||
| Cell and immune therapy for haematological disease - regulation and therapy | P o s t e r E x h i b i t i o n |
I n d u s t r i a l E x h i b i t i o n |
|||||||||
| 9:00- 9:30am | Niederwieser, Dietger Cell therapy for immune disorders |
||||||||||
| 9:30- 10:30am | Presentations from the abstracts | ||||||||||
| 10:30- 11:00am | Coffee break and poster viewing | ||||||||||
| 11:00- 11:30am | Snowden, John Haematopoietic stem cell transplantation in autoimmune disease - Evolution and current EBMT strategy |
||||||||||
| 11:30am- 12:30pm | Presentations from the abstracts | ||||||||||
